Viewing Study NCT06001658


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-01-02 @ 6:00 AM
Study NCT ID: NCT06001658
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2023-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module